The Biotech industry has been flat over the last week, but Moderna has lost 14%. As for the the longer term, the industry is up 5.4% over the past 12 months. As for the next few years, earnings are expected to grow by 25% per annum.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 01 Jun 2024 | US$1.1t | US$164.6b | -US$26,677,227,566.32 | 27.4x | -41.6x | 6.7x |
Mon, 29 Apr 2024 | US$1.1t | US$164.6b | -US$27,372,800,636.09 | 22.6x | -39.1x | 6.5x |
Wed, 27 Mar 2024 | US$1.2t | US$164.4b | -US$23,792,606,116.02 | 21.2x | -48.8x | 7.1x |
Fri, 23 Feb 2024 | US$1.2t | US$169.0b | -US$20,212,652,991.58 | 13.2x | -57x | 6.8x |
Sun, 21 Jan 2024 | US$1.4t | US$204.8b | -US$22,506,538,466.00 | 18.5x | -63.3x | 7x |
Tue, 19 Dec 2023 | US$1.4t | US$204.7b | -US$22,117,247,361.00 | 19.2x | -61x | 6.6x |
Thu, 16 Nov 2023 | US$1.2t | US$204.7b | -US$22,143,559,902.00 | 18.4x | -55.1x | 6x |
Sat, 14 Oct 2023 | US$1.3t | US$207.3b | -US$13,141,713,262.00 | 16.6x | -96.4x | 6.1x |
Mon, 11 Sep 2023 | US$1.3t | US$207.5b | -US$12,633,744,533.00 | 17.4x | -101x | 6.1x |
Wed, 09 Aug 2023 | US$1.3t | US$206.4b | -US$12,500,248,802.00 | 16.4x | -101x | 6.1x |
Fri, 07 Jul 2023 | US$1.1t | US$186.2b | -US$16,056,868,924.00 | 13.2x | -69.5x | 6x |
Sun, 04 Jun 2023 | US$1.1t | US$185.9b | -US$16,014,255,509.00 | 11.4x | -71.1x | 6.1x |
Tue, 02 May 2023 | US$1.2t | US$197.0b | -US$6,677,740,450.00 | 14x | -175.7x | 6x |
Thu, 30 Mar 2023 | US$1.1t | US$198.3b | -US$4,280,712,821.00 | 13.8x | -266.8x | 5.8x |
Sat, 25 Feb 2023 | US$1.1t | US$200.5b | -US$3,797,679,065.00 | 14.2x | -295.4x | 5.6x |
Mon, 23 Jan 2023 | US$1.2t | US$203.8b | US$1.8b | 14.4x | 655.9x | 5.7x |
Wed, 21 Dec 2022 | US$1.2t | US$203.3b | US$1.6b | 14.6x | 704x | 5.7x |
Fri, 18 Nov 2022 | US$1.1t | US$202.2b | US$1.2b | 14.7x | 921.2x | 5.5x |
Sun, 16 Oct 2022 | US$1.0t | US$206.0b | US$5.4b | 15.6x | 194.3x | 5.1x |
Tue, 13 Sep 2022 | US$1.1t | US$206.9b | US$5.9b | 15.8x | 185.7x | 5.3x |
Thu, 11 Aug 2022 | US$1.1t | US$208.3b | US$5.7b | 16.6x | 196.3x | 5.4x |
Sat, 09 Jul 2022 | US$1.1t | US$211.5b | US$10.8b | 17.4x | 102.3x | 5.2x |
Mon, 06 Jun 2022 | US$1.0t | US$212.8b | US$11.3b | 16.4x | 88.7x | 4.7x |
Wed, 04 May 2022 | US$1.0t | US$201.1b | US$7.4b | 17.2x | 140.3x | 5.2x |
Fri, 01 Apr 2022 | US$1.3t | US$221.5b | US$11.4b | 19.1x | 111.5x | 5.7x |
Sun, 27 Feb 2022 | US$1.2t | US$222.9b | US$10.9b | 19.5x | 113.2x | 5.5x |
Tue, 25 Jan 2022 | US$1.2t | US$212.0b | US$2.5b | 23.8x | 496.5x | 5.8x |
Thu, 23 Dec 2021 | US$1.4t | US$212.0b | US$2.8b | 27.2x | 511.5x | 6.8x |
Sat, 20 Nov 2021 | US$1.4t | US$212.2b | US$3.3b | 27.3x | 442.8x | 6.8x |
Mon, 18 Oct 2021 | US$1.5t | US$196.3b | -US$2,601,699,037.00 | 23.6x | -565.4x | 7.5x |
Wed, 15 Sep 2021 | US$1.6t | US$196.4b | -US$2,312,118,480.56 | 21.6x | -682.1x | 8x |
Fri, 13 Aug 2021 | US$1.6t | US$197.0b | -US$1,662,914,785.58 | 22.7x | -936x | 7.9x |
Tue, 08 Jun 2021 | US$1.4t | US$174.8b | -US$11,505,542,875.55 | 22.2x | -120.4x | 7.9x |
-120.4x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -0.63% | |
Healthcare | -0.67% | |
Biotech | -0.34% | |
Biotech | -0.34% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ABBV AbbVie | US$161.24 | 2.7% +US$7.4b | 17.8% | PE47.8x | |
INSM Insmed | US$55.05 | 150.2% +US$5.6b | 181.7% | PS28.1x | |
SMMT Summit Therapeutics | US$8.69 | 157.0% +US$3.7b | 379.8% | PB137.9x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
GRPH Graphite Bio | US$22.26 | 539.7% +US$1.1b | 861.6% | PB7.1x |